Singapore: Biohit Oyj a global Finnish company has signed a distribution agreement with Giraffes Pharmaceutical, Taiwan. This provides Giraffes with the exclusive distribution rights for Acetium capsules and lozenges in Taiwan.

CEO Mr Semi Korpela, Biohit Oyj said that they were pleased to join with Giraffes and introduce Acetium in the Taiwnaese markets. Acetium capsules are used for treating upper digestive tract cancers that represent over 20 percent of all cancers in Taiwan.

Mr Sherman Jung, Giraffes Pharmaceutical CEO said that the partnership with Biohit would help us introduce these capsules in the market and improve the quality of life of the people. He noted that 20 percent of Taiwanese adults are smokers and that this drug would help in lowering the harmful effects of carcinogens in cigarettes.